Drugs MVST IB - part 1

Random Science or description Quiz

Can you name the drugs from MVST IB - part 1?

Quiz not verified by Sporcle

How to Play
DescriptionDrug nameUse
Non-selective phosphodiesterase inhibitor
Competitive inhibitor of tyrosine hydroxylase
Experimental cardiac glycoside
Single chain recombinant human tissue plasminogen activator
Blocks release of neurotransmitter via phospholipase A2 - localises to membrane by K channel binding moiety
Selective alpha-2 agonist
Irreversible alpha-adrenoceptor antagonist - blocks Uptake 2 (and Uptake 1 at 10x higher concs)
Calcium sensitiser - increases cardiac Ca2+ binding efficiency to troponin - inhibits phosphodiesterase III
ADP-ribosylates alpha-s - inhibits GTPase activity - sustained activation of adenylyl cyclase
Inhibits intestinal absorption of cholesterol - circulates enterohepatically
Slightly selective alpha-2 agonist (also alpha-1 actions) - omitting dose can lead to rebound hypertension
Mild partial beta-1 agonist
Selective antagonist for M3 muscarinic receptor
Tyrosine kinase inhibitor
Calcium channel blocker - phenylalkylamine - class IV antidysrhythmic
Beta-1 agonist - weak beta-2 agonist
Anion exchange resin - prevents reuptake of bile acids from intestine
Selective non-depolarising neuromuscular blocker at NMJ - ester, broken down by spontaneous hydrolysis and plasma esterases
Mineralocorticoid receptor agonist
Inhibits DOPA decarboxylase in periphery
Intracellular tetravalent polyamine - helps produce inward rectification of K+ channels
Thiazide diuretic - blocks Na/Cl transport in early distal tubule
Reverse inhibition of AChE by organophosphorus agents
Irreversibly alkylates muscarinic receptor
Calcium channel blocker - benzothiazepine
Non-selective beta-adrenoceptor antagonist
Uncompetitive inhibitor of phosphatase acting on IP1 --> inositol
Arteriolar vasodilator - unknown mechanism
Tricyclic antidepressant - blocks NET
Osmotic diuretic - filtered at glomerulus, not reabsorbed
Selective beta-2 antagonist (slight effect on beta-1)
Non-selective, reversible MAO inhibitor
Competitive antagonist for ganglionic nicotinic receptor - inactive at NMJ
Blocks uptake of choline into neurons
Reversible anticholinesterase - ionic interaction
Irreversible anticholinesterase - organophosphorus agent
Competitively inhibits plasminogen activation - inhibits severe bleeding from excessive clot lysis
Selective MAO-B inhibitor
Potassium-sparing diuretic - blocks apical Na+ channels in late distal tubule
Non-selective agonist for muscarinic receptors
Blocks If current in SA node
Glucocorticoid receptor agonist
Loop diuretic - blocks Na/K/2Cl transport in thick ascending limb
Irreversible anticholinesterase - activated by replacement of sulphur atom with oxygen, deoxified by plasma carboxylesterases
Partial agonist at alpha-adrenoceptors - 5-HT agonist
Local anaesthetic - slow onset/offset - use dependence at low rates of stimulation - class IA antidysrhythmic
Indirectly-acting sympathomimetic amine - weak inhibitor of MAO
Estrogen receptor agonist
Selective MAO-A inhibitor
Angiotensin II partial agonist
Interferes with normal function of microtubule growth
Blocks transporter carrying ACh into storage vesicles
DescriptionDrug nameUse
Cholinergic agonist - +-isomer hydrolysed by AChE
Non-specific endothelin receptor antagonist
Inodilator used to treat canine dilated cardiomyopathy - calcium sensitiser
Selective beta-1 antagonist (slight effect on beta-2)
Class III antidysrhythmic - prolongs AP and refractory period
Potassium-sparing diuretic - blocks apical Na+ channels in late distal tubule
Immunosuppressant drug with antiproliferative effects
Cholinergic agonist - not selective between nicotinic/muscarinic receptors
Binds to synaptobrevin to prevent vesicle release from inhibitory interneuron synapses with motor neurons
Blocks Na channels from exterior - no use-dependence
Illegal drug - blocks NET
Local anaesthetic (ester, weak base) - broken down by BuChE
Acts on imidazoline receptors
Co-released with NA or ACh - acts on purinoceptors (P2 > P1)
Inhibits clotting by inhibiting synthesis of factors II, VII, IX, IX and regulatory proteins C, S, Z
Use-dependent block of ganglionic transmission
Non-selective phosphodiesterase inhibitor
Selective alpha-2 antagonist (slight effect on alpha-1)
PPAR-gamma agonist
Selective beta-2 agonist (slight effect on beta-1)
K channel opener - also NO donor
Binds very tightly to VMAT-2, preventing loading of catecholamines into vesicles
Nitrovasodilator - produces NO - metabolised in liver to active drug
Selective alpha-1 antagonist (slight effect on alpha-2)
Beta-1 antagonist used in heart failure
Orally-acting hypoglycaemic agent - sulphonylurea
ACE inhibitor
Blocks transport of adenosine into cells - phosphodiesterase type V inhibitor
Tricyclic antidepressant - blocks NET
Blocks release of NA evoked by APs (repeated low doses/aftermath of large dose) - indirect sympathomimetic actions (large doses)
Muscarinic receptor agonist
Selective alpha-1 agonist (some action on beta-1)
Selective antagonist for M1 muscarinic receptors
Lowers VLDL (and LDL) by stimulating lipoprotein lipase - may activate PPARs
Glucocorticoid receptor antagonist
Plasminogen + anisoylated streptokinase
COMT inhibitor
Competitively inhibits plasminogen activation - inhibits severe bleeding from excessive clot lysis
Depolarising blocker selective for NMJ nicotinic receptor - very short duration of action, broken down by BuChe - deficiency in enzyme activity can lead to prolonged action
Non-selective agonist for muscarnic receptors
Used experimentally to inhibit dopamine beta-hydroxylase - also inhibits aldehyde dehyddrogenase
Selective inhibitor of NOS in neurons
K channel opener
K channel opener
Phosphodiesterase III inhibitor - inodilator
Monoclonal antibody against glycoprotein IIb/IIIa receptor - prevents platelet aggregation - also binds to vitronectin receptor
Beta-adrenoceptor agonist
Progestagen receptor agonist
Calcium channel antagonist - dihydropyridine - affects L-type but not T-type channels
Potent, irreversible inhibitor of iNOS in activated macrophages
NOS inhibitor - not very selective for different forms
Cardiac glycoside - inhibits Na/K-ATPase
DescriptionDrug nameUse
Involved with providing new blood flow to ischaemic tissues
Competitive antagonist for ganglionic nicotinic receptors - inactive at NMJ
Direct acting vasodilator - metabolised to NO or cyanide
Indirectly acting sympathomimetic amine - converted to octopamine by DBH - found in various foodstuffs
Muscarinic receptor antagonist - very long duration of action
ACE inhibitor - prodrug, must be metabolised in liver
Progestagen receptor antagonist
K channel opener - also hirsutism effects
Binds to plasminogen activator, increasing generation of plasmin
Binds to SNAREs involved in membrane fusion, preventing ACh release
alpha-1 antagonist most commonly used
Medium 'reversible' anticholinesterase - binds to esteratic site and carbamoylates ACh
Non-peptide angiotensin II antagonist - acts on AT1 receptors
Orally-acting hypoglycaemic agent - sulphonylurea
Inhibits platelet activation by inhibiting binding of ADP to its receptor on platelets
A1 receptor antagonist - non-selective phosphodiesterase inhibitor
Very potent alpha-2 agonist
Mineralocorticoid receptor antagonist - potassium-sparing diuretic
Quaternary local anaesthetic analogue - only effective if perfused inside cells
Non-peptide inhibitor of glycoprotein IIb/IIIa receptor
Alpha-2 antagonist (some effect on alpha-1)
Acts on imidazoline receptors
Selective inhibitor of phosphodiesterase type V (selectively breaks down cGMP)
Phosphodiesterase III inhibitor - inodilator
Depolarising blocker selective for ganglion nicotinic receptor
Cyclic heptapeptide inhibitor of glycoprotein IIb/IIIa receptor
Local anaesthetic - weak base - use-dependence and voltage-dependence
Regulates expression of multiple angiogenic genes
Local anaesthetic - uncharged
Binds to neurexins, causing massive ACh release from nerve terminals
Nitrovasodilator - produces NO
NSAID used to prevent thrombosis
Naturally occurring anticoagulant produced by basophils/mast cells - exposes active site of antithrombin III
Non-selective alpha-adrenoceptor antagonist
Class IC antidysrhythmic
Causes development of new blood vessels
Nitrovasodilator - produces NO - taken sublingually
Irreversible antagonist at nicotinic NMJ receptors (no effect on ganglionic receptors)
Nicotinic receptor antagonist - relatively non-selective between NMJ and ganglion at clinical doses
Estrogen receptor antagonist
Depolarising blocker at NMJ
Converted to alpha-methylNA - released as false transmitter - more potent at alpha-2, less potent at alpha-1
Selective non-depolarising neuromuscular blocking agent at NMJ - long action, not hydrolysed
Combined alpha- and beta-adrenoceptor antagonist
Inhibits liver triglyceride production and VLDL secretion - increases levels of tissue plasminogen activator
Calcium channel agonist - dihydropyridine
SSRI - blocks 5-HT transporter in Uptake 1
Beta-1 antagonist used in heart failure
Carbonic anhydrase inhibitor
Inhibits HMG-CoA reductase - also many pleiotropic effects
ADP-ribosylates alpha-i - prevents activation of Gi in response to stimulation
Double chain recombinant human tissue plasminogen activator

Friend Scores

  Player Best Score Plays Last Played
You You haven't played this game yet.

You Might Also Like...


Created May 3, 2010ReportNominate
Tags:description, drug